查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571459

腎衰竭治療市場規模、佔有率、趨勢分析報告：按治療、最終用途、地區和細分市場預測，2024-2030 年

Renal Failure Treatment Market Size, Share & Trends Analysis Report By Treatment (Dialysis, Kidney Transplantation, Drug Therapy), By End-use (Hospitals, Specialty Clinics), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

腎衰竭治療市場的成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球腎衰竭治療市場規模將達到1971億美元，2024年至2030年複合年成長率為8.3%。

該市場包括旨在管理和治療慢性腎臟病（CKD）和末期腎臟病（ESRD）的各種產品和服務。

慢性腎臟病病盛行率的增加是關鍵的市場促進因素。發生率的增加主要是由於糖尿病和高血壓的盛行率增加，這兩種疾病是腎臟疾病的已知危險因子。隨著人口老化和這些慢性疾病變得更加普遍，對腎衰竭治療的需求將繼續成長，給醫療保健系統帶來額外的壓力，以提供足夠的照護。

對腎臟健康的認知和教育不斷提高是市場的關鍵驅動力。旨在教育個人了解腎臟疾病的風險和症狀的公共衛生宣傳活動和舉措有助於早期診斷和早期治療。認知的提高將鼓勵患者儘早醫，最終導致及時干預並改善腎臟疾病的管理。

2023 年 10 月，Zydus Lifesciences Limited 和 Sun Pharmaceutical Industries Limited (Sun Pharma) 簽訂了授權合約，共同銷售 Desidustat，這是印度第一種治療慢性腎臟病(CKD) 所致貧血的口服藥物。 desidustat 的授權合約代表了市場的重大發展，為 CKD 相關貧血提供了新的口服治療選擇，加強了患者照護並擴大了印度的市場進入。

腎衰竭治療市場報告亮點

  • 從治療方法來看，透析療法將佔據市場主導地位，2023年銷售佔有率將達到72.34%。 CKD 和 ESRD 盛行率的上升推動了對腎臟替代治療的需求。這一趨勢的主要促進因素包括人口老化、透析技術的進步以及腎臟健康意識的提高。
  • 以最終用途分類，醫院佔據市場主導地位，2023 年銷售佔有率最大，為 57.64%。推動這一成長的因素包括接受透析和移植手術的患者入院人數增加、腎臟護理設備的技術進步以及醫院為處理複雜病例提供的綜合醫療服務。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章腎衰竭治療市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 腎衰竭治療市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章腎衰竭治療市場：治療估計與趨勢分析

  • 全球腎衰竭治療市場：治療儀表板
  • 全球腎衰竭治療市場：治療變異分析
  • 全球腎衰竭治療市場：依治療、收益
  • 透析
  • 腎臟移植
  • 藥物治療
  • 其他

第5章腎衰竭治療市場：最終用途估計與趨勢分析

  • 全球腎衰竭治療市場：最終用途儀表板
  • 全球腎衰竭治療市場：最終用途變化分析
  • 按最終用途分類的收益
  • 醫院
  • 專科診所
  • 其他

第6章腎衰竭治療市場：按治療/最終用途分類的區域估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模及預測趨勢分析：
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第7章 競爭格局

  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • Key company market share analysis, 2023
    • NIPRO
    • Fresenius Medical Care AG
    • Baxter
    • Medtronic
    • B. Braun SE
    • Asahi Kasei Medical Co., Ltd.
    • AbbVie Inc.
    • Nikkiso Co., Ltd.
    • JMS Co., Ltd.
    • AstraZeneca
Product Code: GVR-4-68040-441-7

Renal Failure Treatment Market Growth & Trends:

The global renal failure treatment market size is anticipated to reach USD 197.1 billion by 2030 and is anticipated to grow at a CAGR of 8.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market encompasses a range of products and services designed to manage and treat chronic kidney disease (CKD) and end-stage renal disease (ESRD).

The increasing prevalence of chronic kidney disease is a significant market driver. The growing incidence is largely attributed to the rising rates of diabetes and hypertension, which are known risk factors for kidney disease. As the population ages and these chronic conditions become more prevalent, the need for renal failure treatment continues to grow, placing additional pressure on healthcare systems to provide adequate care.

Rising awareness and education about kidney health are crucial market drivers. Public health campaigns and initiatives aimed at educating individuals about the risks and symptoms of kidney disease have contributed to earlier diagnosis and treatment. The heightened awareness encourages patients to seek medical advice sooner, ultimately leading to timely interventions and improved management of kidney conditions.

In October 2023, Zydus Lifesciences Limited and Sun Pharmaceutical Industries Limited (Sun Pharma) entered a licensing agreement to co-commercialize Desidustat, the first oral drug in India to treat anemia caused by chronic kidney disease (CKD). The licensing agreement for Desidustat represents a significant development in the market by providing a novel oral treatment option for anemia associated with CKD, enhancing patient care, and expanding market access in India.

Renal Failure Treatment Market Report Highlights:

  • Based on treatment, dialysis dominated the market with the largest revenue share of 72.34% in 2023. The rising prevalence of CKD and ESRD is driving the demand for renal replacement therapies. Major factors contributing to this trend include an aging population, technological advancements in dialysis, and increased kidney health awareness
  • Based on end-use, hospitals dominated the market with the largest revenue share of 57.64% in 2023. Factors driving this growth include a rise in patient admissions for dialysis and transplant procedures, technological advancements in renal care equipment, and comprehensive healthcare services provided by hospitals that cater to complex cases

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Treatment
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Treatment Outlook
    • 2.2.2. End Use Outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Renal Failure Treatment Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increased prevalence of CKD
      • 3.2.1.2. Advancements in treatment technologies
      • 3.2.1.3. Rising awareness and education about kidney health
      • 3.2.1.4. Aging population
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of treatment
      • 3.2.2.2. Limited Healthcare Resources and Access
  • 3.3. Renal Failure Treatment Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Renal Failure Treatment Market: Treatment Estimates & Trend Analysis

  • 4.1. Global Renal Failure Treatment Market: Treatment Dashboard
  • 4.2. Global Renal Failure Treatment Market: Treatment Movement Analysis
  • 4.3. Global Renal Failure Treatment Market by Treatments, Revenue
  • 4.4. Dialysis
    • 4.4.1. Dialysis market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.2. Hemodialysis
      • 4.4.2.1. Hemodialysis market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.3. Peritoneal Dialysis
      • 4.4.3.1. Peritoneal Dialysis market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.5. Kidney Transplantation
    • 4.5.1. Kidney transplantation market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.6. Drug Therapy
    • 4.6.1. Drug therapy market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.6.2. Antihypertensive Drugs
      • 4.6.2.1. Antihypertensive Drugs market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.6.3. Antianemia Therapeutics (Erythropoiesis-Stimulating Agents)
      • 4.6.3.1. Antianemia therapeutics (Erythropoiesis-Stimulating Agents) market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.6.4. Potassium Binders
      • 4.6.4.1. Potassium Binders market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.6.5. Phosphate Binders
      • 4.6.5.1. Phosphate Binders market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. Renal Failure Treatment Market: End Use Estimates & Trend Analysis

  • 5.1. Global Renal Failure Treatment Market: End Use Dashboard
  • 5.2. Global Renal Failure Treatment Market: End Use Movement Analysis
  • 5.3. Global Renal Failure Treatment Market Estimates and Forecasts, By End Use, Revenue (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.5. Specialty Clinics
    • 5.5.1. Specialty clinics market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. Renal Failure Treatment Market: Regional Estimates & Trend Analysis by Treatment, and End Use

  • 6.1. Regional Dashboard
  • 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework/ reimbursement structure
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Vendor Landscape
    • 7.2.1. List of key distributors and channel partners
    • 7.2.2. Key company market share analysis, 2023
    • 7.2.3. NIPRO
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Fresenius Medical Care AG
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Baxter
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Medtronic
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. B. Braun SE
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Asahi Kasei Medical Co., Ltd.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. AbbVie Inc.
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Nikkiso Co., Ltd.
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. JMS Co., Ltd.
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. AstraZeneca
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America renal failure treatment market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 4 North America renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 5 U.S. renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 6 U.S. renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 8 Canada renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Mexico renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 10 Mexico renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe renal failure treatment market, by region, 2018 - 2030 (USD Million)
  • Table 12 Europe renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 13 Europe renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Germany renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 15 Germany renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 16 UK renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 17 UK renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 18 France renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 19 France renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Italy renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 21 Italy renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Spain renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 23 Spain renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Denmark renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 25 Denmark renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Sweden renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 27 Sweden renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Norway renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 29 Norway renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific renal failure treatment market, by region, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 33 China renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 34 China renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Japan renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 36 Japan renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 37 India renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 38 India renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 39 South Korea renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 40 South Korea renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Australia renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 42 Australia renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Thailand renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 44 Thailand renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Latin America renal failure treatment market, by region, 2018 - 2030 (USD Million)
  • Table 46 Latin America renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 47 Latin America renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Brazil renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 49 Brazil renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Argentina renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 51 Argentina renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 52 MEA renal failure treatment market, by region, 2018 - 2030 (USD Million)
  • Table 53 MEA renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 54 MEA renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 55 South Africa renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 56 South Africa renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 59 UAE renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 60 UAE renal failure treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait renal failure treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 62 Kuwait renal failure treatment market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market research approaches
  • Fig. 4 QFD modeling for market share assessment
  • Fig. 5 Market formulation & validation
  • Fig. 6 Renal failure treatment market: market outlook
  • Fig. 7 Renal failure treatment competitive insights
  • Fig. 8 Parent market outlook
  • Fig. 9 Related/ancillary market outlook
  • Fig. 10 Renal failure treatment market driver impact
  • Fig. 11 Renal failure treatment market restraint impact
  • Fig. 12 Renal failure treatment market: Treatment movement analysis
  • Fig. 13 Renal failure treatment market: Treatment outlook and key takeaways
  • Fig. 14 Dialysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Hemodialysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Peritoneal dialysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Kidney transplantation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Drug therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Antihypertensive drugs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Antianemia therapeutics (erythropoiesis-stimulating agents) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Potassium binders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Phosphate binders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Renal failure treatment market: End use movement analysis
  • Fig. 25 Renal failure treatment market: End use outlook and key takeaways
  • Fig. 26 Hospital market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Specialty clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Global renal failure treatment market: Regional movement analysis
  • Fig. 30 Global renal failure treatment market: Regional outlook and key takeaways
  • Fig. 31 Global renal failure treatment market share and leading players
  • Fig. 32 North America, by country
  • Fig. 33 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. key country dynamics
  • Fig. 35 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Canada key country dynamics
  • Fig. 37 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Mexico key country dynamics
  • Fig. 39 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 UK key country dynamics
  • Fig. 42 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Germany key country dynamics
  • Fig. 44 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 France key country dynamics
  • Fig. 46 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Italy key country dynamics
  • Fig. 48 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Spain key country dynamics
  • Fig. 50 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Denmark key country dynamics
  • Fig. 52 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Sweden key country dynamics
  • Fig. 54 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Norway key country dynamics
  • Fig. 56 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 China key country dynamics
  • Fig. 59 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Japan key country dynamics
  • Fig. 61 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 India key country dynamics
  • Fig. 63 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Thailand key country dynamics
  • Fig. 65 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 South Korea key country dynamics
  • Fig. 67 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Australia key country dynamics
  • Fig. 69 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Brazil key country dynamics
  • Fig. 72 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Argentina key country dynamics
  • Fig. 74 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 South Africa key country dynamics
  • Fig. 77 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Saudi Arabia key country dynamics
  • Fig. 79 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 UAE key country dynamics
  • Fig. 81 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Kuwait key country dynamics
  • Fig. 83 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Market share of key market players- renal failure treatment market